MichBio is pleased to present a signature webinar on the State of Pharma and Biotech Investments with Guest Speakers from JPMorgan
The combined impact of drug pricing reform and patient affordability, a global pandemic, and increasing public pressure on pharmaceutical companies and the life science industry to put consumers at the center of research has made healthcare THE issue concerning voters, policy-makers, and the general public. The focus begets the question - what is the current state of the industry? |
|
|
|
|
|
|